Start Time: 16:30 January 1, 0000 4:57 PM ET Guardant Health, Inc. (NASDAQ:GH) Q1 2021 Earnings Conference Call May 06, 2021, 16:30 PM ET Company Participants Helmy Eltoukhy - CEO AmirAli Talasaz - President and COO Mike Bell - CFO Carrie Mendivil - IR Conference Call Participants Operator Thank you for standing by, and welcome to the Guardant Health Q1 2021 Earnings Call. All lines are currently in a listen-only mode. After the speakers' presentation, there will a question-and-answer session. [Operator Ins ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38683 _____________________ GUARDANT HEALTH, INC. (Exact Name of Registrant as Specif ...

Guardant Health, Inc. (NASDAQ:GH) Q4 2020 Earnings Conference Call February 24, 2021 5:00 PM ET Company Participants Carrie Mendivil - Investor Relations Helmy Eltoukhy - Co-Founder & Chief Executive Officer AmirAli Talasaz - Co-Founder & President Mike Bell - Chief Financial Officer Conference Call Participants Brian Weinstein - William Blair Tycho Peterson - JPMorgan Doug Schenkel - Cowen Puneet Souda - SVB Leerink Tejas Savant - Morgan Stanley Derik de Bruin - Bank of America Patrick Donnelly - Citi Dan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________________ FORM 10-K _____________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38683 _____________________ GUARDANT HEALTH, INC. (Exact Name of Registrant as Specified i ...

Guardant Health, Inc. (NASDAQ:GH) Q3 2020 Results Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Carrie Mendivil - IR Helmy Eltoukhy - Co-Founder & CEO AmirAli Talasaz - Co-Founder & President Derek Bertocci - CFO Conference Call Participants Puneet Souda - SVB Tycho Peterson - JPMorgan Doug Schenkel - Cowen Derik de Bruin - Bank of America Brian Weinstein - William Blair Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Sung Ji Nam - BTIG Operator Ladies and gentlemen, thank ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________________ ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38683 _____________________ GUARDANT HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) _____________________ (State or other jurisdiction of incorporation or organization) FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SEC ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38683 _____________________ GUARDANT HEALTH, INC. (Exact Name of Registrant as Specifi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________________ FORM 10-Q _____________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38683 _____________________ GUARDANT HEALTH, INC. (Exact Name of Registrant as Specif ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________________ FORM 10-K _____________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38683 _____________________ GUARDANT HEALTH, INC. (Exact Name of Registrant as Specified i ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _____________________ FORM 10-Q _____________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 GUARDANT HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) _____________________ (State or other jurisdiction of incorporation or organization) 505 Penobscot Dr. For the quarterly period ended September 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF ...